In this article, we are going to discuss the 10 best 52-week high stocks to buy according to analysts.
Volatility in the equity markets under President Donald Trump has already hit record highs. Amid the heightened volatility, US equities have also bounced back on optimism about US-China trade negotiations. Robust economic data has also eased recession fears, which has seen some stocks rally to 52-week highs.
According to Lain Barnes, chief investment officer at London-based wealth manager Netwealth US, the Market continues to look “surprisingly resilient given what’s been thrown at it.” That’s evident as the S&P 500 is still up by 12% over the past 12 months.
READ ALSO: 10 Most Popular AI Stocks to Avoid Now and Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential.
“Profit margins are at historically strong levels, spurring a strong rebound since the Liberation Day-induced panic, so valuations remain our primary concern here. Heat has come out of the labor market and inflation is also cooling for now,” Barnes said.
Analysts at Citigroup have already raised their year-end S&P 500 target by about 9% to 6,300 from 5,800. According to strategist Scott Chronert, market fundamentals remain solid, affirming the case for the 14 best 52-week high stocks to buy, according to analysts.
“What the first half has told us is that fundamental volatility may be more manageable as tariffs, taxes, budget/deficit, rates, currency, geopolitics, etc. will all continue to remain in the financial news headlines,” Chronert said.
The remarks come as markets remain less worried about rising trade tensions between the US and other countries. The fact that the S&P 500 is about 2% off its record highs underscores renewed investor sentiments after the slump in April.
With that in mind, let’s take a look at the 14 best 52-week High Stocks to Buy, According to Analysts.
A senior manager studying a market index alongside a team of young stock market analysts.
Our Methodology
We sifted through the US equity markets and settled on the 10 best 52-week high stocks to buy, according to analysts. We settled on stocks trading at 52-week highs (0%-5%) and rated as a Buy by analysts. These stocks are also popular among elite hedge funds as of Q1 2025. Finally, we ranked the stocks in ascending order based on their upside potential (more than 5%).
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Best 52-Week High Stocks to Buy According to Analysts
10. HSBC Holdings plc (NYSE:HSBC)
52 Week Range: $39.42 – $61.88
Current Share Price as of June 11: $59.50
Stock Upside Potential as of June 11: 5.85%
HSBC Holdings PLC (NYSE:HSBC) is one of the best 52-week high stocks to buy, according to analysts. On June 10, the company announced the first interim dividend for the December 31, 2025 financial year.
The company is to pay a dividend of $0.10 per ordinary share on June 20, 2025, to shareholders on record as of May 9, 2025. The Payment is in response to the approval by the company’s board of Directors on April 29, 2025.
HSBC Holdings PLC (NYSE:HSBC) is a global banking and financial services institution. It offers various financial services to individuals, businesses, and institutions worldwide. It provides financial solutions to individuals, businesses, governments, and institutions across multiple regions.
9. Intuit Inc. (NASDAQ:INTU)
52 Week Range: $532.64 – $773.45
Current Share Price as of June 11: $763.72
Stock Upside Potential as of June 11: 6.72%
Intuit Inc. (NASDAQ:INTU) is one of the best 52-week high stocks to buy, according to analysts. That was evident on June 9 as Mizuho Securities increased the stock’s price target to $875 from $825. In addition, it reaffirmed its ‘Outperform’ rating.
The price target adjustment follows an analysis of the company’s QuickBooks business after a robust TurboTax season. Siti Panigrahi and analysts at the research firm expect Intuit’s online ecosystem revenue to grow at a compound annual growth rate of 22% between 2026 and 2028, beating consensus estimates of 18%.
The expected growth should be accelerated by increased traction in the mid-market segment through products like QBO Advanced and IEX. Additionally, Intuit is expected to benefit from the broader adoption driven by portfolio expansion. Integration of artificial intelligence agents in QuickBooks is also likely to accelerate upgrades.
Panigrahi expects Intuit’s stock valuation to receive a significant boost given the anticipated growth complimented by double-digit growth in the Consumer segment. The company’s solid performance in fiscal 2025, ongoing margin expansion, and increased monetization of AI technologies are also expected to bolster the stock’s sentiments.
Intuit Inc. (NASDAQ:INTU) is a technology company that provides financial management, compliance, and marketing products and services. It provides QuickBooks services, including online financial and business management, desktop software, bill pay solutions, checking accounts, and financing services.
8. AT&T Inc. (NYSE:T)
52 Week Range: $17.42 – $29.03
Current Share Price as of June 11: $28.46
Stock Upside Potential as of June 11: 7.06%
AT&T Inc. (NYSE:T) is one of the best 52-week high stocks to buy, according to analysts. On June 10, the company confirmed the expansion of its fiber network to more than 30 million consumer and business locations across the US.
The expansion cements the company’s position as the leading fiber internet provider. The company is targeting more than 60 million locations by 2030. AT&T also focuses on growing its organic in-region fiber network, Gigapower joint venture, and public-private partnerships. It is also acquiring Lumen’s Mass Market fiber business to access over 1 million fiber customers and more than 4 million fiber locations.
The expansion drive is part of AT&T’s push to meet increasing customer demand for broadband technology. With the fiber and 5G combination, AT&T provides American customers with greater options for choosing broadband and wireless services. Customers are likely to stick with AT&T longer and refer others to the company if they use AT&T Fiber and its wireless services.
AT&T Inc. (NYSE:T) is a telecommunications company providing a wide range of services, primarily connecting people and businesses. They offer mobile phone plans, fixed-line phone services, broadband internet, and even pay television.
7. McKesson Corporation (NYSE:MCK)
52 Week Range: $464.42 – $731
Current Share Price as of June 11: $713.05
Stock Upside Potential as of June 11: 8.22%
McKesson Corporation (NYSE:MCK) is one of the best 52-week high stocks to buy, according to analysts. On June 10, Wells Fargo reiterated an Equal Weight on the stock and a $766 price target. The bullish stance is in response to the company increasing its full-year earnings per share guidance by 0.5%.
The company has raised the bar for its performance by adjusting its full-year EPS guidance. It underscores prospects of a potential increase in profitability amid underlying growth. Nevertheless, Wells Fargo remains cautious, insisting the stock is adequately valued at current levels.
The remarks come on the company completing the acquisition of a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures. The $2.49 billion acquisition is part of the company’s strategy of enhancing community-based oncology care.
McKesson Corporation (NYSE:MCK) is a diversified healthcare services company that is a major pharmaceutical supply chain player. It provides distribution, healthcare services, and medical supplies and equipment. It works with various partners, including biopharma companies, healthcare providers, pharmacies, manufacturers, and governments.
6. The Williams Companies, Inc. (NYSE:WMB)
52 Week Range: $40.41 – $61.66
Current Share Price as of June 11: $59.41
Stock Upside Potential as of June 11: 8.52%
Williams Companies Inc. (NYSE:WMB) is one of the best 52-week high stocks to buy, according to analysts. On June 10, an analyst at UBS reiterated a ‘Buy’ rating on the stock with a $74 price target. The analysts remain bullish about the company’s strategic plans for pipeline projects.
The company plans to start constructing the Northeast Supply Enhancement (NESE) project in the third quarter. The company also hopes to secure regulatory approval from the Federal Energy Regulatory Commission (FERC) for its Constitution pipeline, which will begin in October of next year.
The company’s CEO, Alan Armstrong, reiterated that the NESE project is straightforward compared to the Constitution pipeline. Consequently, he expects the NESE project to move forward compared to the Constitution project. Williams Companies is looking for potential partners to support the development of the Constitution project.
Williams Companies Inc. (NYSE:WMB) operates an extensive network of natural gas pipelines and gathering and processing operations in the United States. It handles about a third of the nation’s natural gas every day. It invests in high-return projects, including renewable energy and emissions reduction efforts.
5. Waste Management, Inc. (NYSE:WM)
52 Week Range: $196.59 – $242.58
Current Share Price as of June 11: $234.10
Stock Upside Potential as of June 11: 8.79%
Waste Management Inc. (NYSE:WM) is one of the best 52-week high stocks to buy, according to analysts. On June 10, Melius Research’s analyst initiated stock coverage with a ‘Buy’ rating and a $263 price target. The bullish stance stems from expectations of short- and long-term performance.
According to the research firm, there is reduced risk and limited earnings downside. In addition, the company has shown significant growth potential. While the stock trades at a premium, it aligns with historical averages.
Waste Management boasts a competitive edge in the sector as it can leverage strong pricing power through contractual agreements. That was evident as the company reported a strong start to 2025. Its first-quarter results exceeded expectations, characterized by a 12% growth in operating EBITDA.
Waste Management Inc. (NYSE:WM) provides environmental solutions to residential, commercial, industrial, and municipal customers. It offers collection services, including picking up and transporting waste and recyclable materials from where it was generated to a transfer station, recovery facility, or disposal site.
4. Paychex, Inc. (NASDAQ:PAYX)
52 Week Range: $115.41 – $161.24
Current Share Price as of June 11: $154.80
Stock Upside Potential as of June 11: 9.38%
Paychex, Inc. (NASDAQ:PAYX) is one of the best 52-week high stocks to buy, according to analysts. On June 10, Morgan Stanley reiterated an ‘Equal Weight’ on the stock and maintained a $150 price target. The firm’s stance is in response to the acquisition of PayCor for $4.1 billion as it seeks to enhance its AI-enabled technology and service capabilities.
According to Morgan Stanley, the acquisition will likely trigger a 5% and 3% decrease in forecasted diluted earnings per share for fiscal 2026 and 2027. Despite the downward adjustment, the firm has reiterated a $150 price target, attributing it to higher earnings multiple of 27 times up from 25 times.
Morgan Stanley is confident of the sustained strength of the demand and employment landscape as the PayCor acquisition is poised to increase Paychex’s total addressable market. The analysts expect the integration to contribute positively to the company’s business by broadening service offerings and reaching new customer segments.
The strategic acquisition is also expected to bolster Paychex’s position in the market by tapping PayCor’s existing customer base and technology solutions. The acquisition is also part of a broader strategy that seeks to capture more market share and drive growth.
Paychex, Inc. (NASDAQ:PAYX) provides integrated human capital management solutions (HCM) for payroll, benefits, human resources (HR), and insurance services for small to medium-sized businesses. It offers payroll processing, tax administration, employee payment, and regulatory compliance services.
3. Cardinal Health, Inc. (NYSE:CAH)
52 Week Range: $93.17 – $157.82
Current Share Price as of June 11: $153.50
Stock Upside Potential as of June 11: 9.42%
Cardinal Health (NYSE:CAH) is one of the best 52-week high stocks to buy, according to analysts. On June 10, analysts at TD Cowen reiterated a Buy rating and maintained a price target of $162 on the stock.
The analysts expect the company to increase its long-term pharmaceutical profit guidance from 5% to 7% from a previous guidance of 4% and 6%. Cardinal Health is also expected to introduce preliminary adjusted earnings per share guidance in the range of $9.15 to $9.45.
TD Cowen analyst also expects Cardinal Health to provide insights on how other segment businesses will contribute 18% of adjusted operating income. The company has entered into a distribution agreement with Citious Oncology to support the launch of FDA-approved immunotherapy LYMPHIR.
Cardinal Health (NYSE:CAH) is a global healthcare company that distributes pharmaceuticals and specialty products. It also manufactures and distributes medical and laboratory products.
2. Cisco Systems, Inc. (NASDAQ:CSCO)
52 Week Range: $44.50 – $66.50
Current Share Price as of June 11: $64.19
Stock Upside Potential as of June 11: 10.29%
Cisco Systems Inc. (NASDAQ:CSCO) is one of the best 52-week high stocks to buy, according to analysts. On June 10, the company unveiled a new secure network architecture designed to accelerate workplace AI transformation. The new architecture addresses urgent challenges in the AI era, including explosive network traffic. It will also address mission-critical uptime requirements and address any security threats.
With the new secure network architecture, Cisco sets up a new standard for organizations to navigate the challenges of skyrocketing cyber threats and network traffic. Consequently, the company will leapfrog the industry by reimagining how networks are managed and secured.
AgenticOps, Cisco’s AI-driven approach to running modern IT operations, will supercharge the new architecture. It’s powered by a new deep network model, a domain-specific large language model trained on decades of company expertise.
The hardware powering the new architecture is orderable this month through the company or through certified partners. The unified management platform is also available as the Cisco AI assistant remains in public beta.
Cisco Systems Inc. (NASDAQ:CSCO) is a technology company revolutionizing how organizations connect and protect in the AI era. It boasts industry-leading AI-powered solutions and services that enable customers, partners, and communities to unlock innovation, enhance productivity, and strengthen digital resilience.
1. Ascendis Pharma A/S (NASDAQ:ASND)
52 Week Range: $111.09 – $183
Current Share Price as of June 11: $173.34
Stock Upside Potential as of June 11: 30.45%
Ascendis Pharma A/S (NASDAQ:ASND) is one of the best 52-week high stocks to buy, according to analysts. On June 9, BofA analyst Tazeen Ahmad reiterated a ‘Buy’ rating on the stock and raised the price target to $216 from $201.
The adjustment follows the company delivering positive interim results from the Phase 2 COACH trial. The trial sought to ascertain the effectiveness of a combination treatment QW TransCon CNP and QW TransCon HGH in children with Achondroplasia (ACH). Trial results indicated significant annualized growth velocity benefits with the combination treatment.
According to the analyst, the trial results are favorable and likely to strengthen the company’s prospects of capturing market share once the treatment enters the market. Following the positive trial results, Ascendis plans to release 52-week data from the COACH trial in the fourth quarter.
Likewise, the US Food and Drug Administration (FDA) has accepted the company’s New Drug Application for TransCon, its candidate drug for treating achondroplasia.
Ascendis Pharma A/S (NASDAQ:ASND) is a biopharmaceutical company that develops and commercializes new therapies for unmet medical needs, particularly in endocrinology and oncology. It leverages a proprietary TransCon technology platform to create innovative and potentially best-in-class therapies.
While we acknowledge the potential of ASND to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ASND and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
